Literature DB >> 7758217

Clinical usefulness of cimetidine treatment for acute relapse in intermittent porphyria.

Y Horie1, M Norimoto, F Tajima, H Sasaki, E Nanba, H Kawasaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7758217     DOI： 10.1016/0009-8981(94)05989-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


× No keyword cloud information.
  5 in total

Review 1.  Acute hepatic porphyrias: Current diagnosis & management.

Authors:  Karl E Anderson
Journal:  Mol Genet Metab       Date:  2019-07-05       Impact factor: 4.797

Review 2.  Porphyrias in Japan: compilation of all cases reported through 2002.

Authors:  Masao Kondo; Yuzo Yano; Masuo Shirataka; Gumpei Urata; Shigeru Sassa
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

3.  Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury.

Authors:  Naoyuki Fujimori; Michiharu Komatsu; Naoki Tanaka; Mai Iwaya; Hajime Nakano; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yugo Iwaya; Takashi Muraki; Yuki Ichikawa; Takefumi Kimura; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Eiji Tanaka
Journal:  Clin J Gastroenterol       Date:  2017-07-04

4.  Interaction of cimetidine with P450 in a mouse model of hepatocarcinogenesis initiation.

Authors:  F Caballero; E Gerez; A Batlle; E Vazquez
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

Review 5.  Advances in the management of erythropoietic protoporphyria - role of afamelanotide.

Authors:  Ashley M Lane; Jerome T McKay; Herbert L Bonkovsky
Journal:  Appl Clin Genet       Date:  2016-12-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.